Sterling Manor Financial, LLC Abb Vie Inc. Transaction History

Sterling Manor Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	BUY	$138.31 - $165.87 $188,654 - $226,246	1,364 New	1,364 $0
Q2 2022 Aug 03, 2022	SELL	$137.62 - $174.96 $405,703 - $515,782	-2,948 Closed	0 $0
Q1 2022 Apr 21, 2022	SELL	$131.98 - $163.75 $81,563 - $101,197	-618 Reduced 17.33%	2,948 $478,000
Q4 2021 Jan 21, 2022	BUY	$107.43 - $135.93 $383,095 - $484,726	3,566 New	3,566 $483,000

3,795

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $353B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Sterling Manor Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Sterling Manor Financial, LLC with notifications on news.